Monoamine Oxidase B Inhibitors in Parkinson's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 4, 2017-07 ,pp. : 425-439

Bentham Science Publishers

Access to resources Recommend Favorite

The increasing role of monoamine oxidase type B inhibitors in Parkinson's disease therapy

By Elmer Lawrence W   Bertoni John M  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2759-2772

Informa Healthcare

Access to resources Recommend Favorite

Anti-apoptotic function of propargylamine inhibitors of type-B monoamine oxidase

By Naoi M.   Maruyama W.   Youdim M. B. H.   Yu P.   Boulton A. A.  

Inflammopharmacology, Vol. 11, Iss. 2, 2003-06 ,pp. : 175-181

VSP

Access to resources Recommend Favorite

Focusing on new monoamine oxidase inhibitors

By Bolasco Adriana   Carradori Simone   Fioravanti Rossella  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 7, 2010-07 ,pp. : 909-939

Informa Healthcare

Access to resources Recommend Favorite

Recent development of monoamine oxidase inhibitors

By Bolasco Adriana   Fioravanti Rossella   Carradori Simone  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 12, 2005-12 ,pp. : 1763-1782

Informa Healthcare

Access to resources Recommend Favorite